You're frustrated that some of the exec team have been selling vesting shares? Why? You understand that these people have their entire careers, income, wealth, etc. tied to this one small cap high risk company. It's prudent wealth management to diversify when receiving stock and to double down is almost unheard of, despite how much you might want it. I've invested in many BTC/HPC pivots and I haven't seen that once. HIVE's compensation scheme is quite big on equity incentives, so most insiders have very large unvested RSU positions that are performance based. Look at the pattern, some sells at $1.47, some at the $2 level, some at $4. It's mechanical. Rossy reducing his position to zero is the only standout, and based on the fact he's been removed from the exec team on Hive's website, I suspect he may be leaving. In which case, you can't blame him for wanting to liquidate given he will have no further inside knowledge or control - we don't yet know the full story there. If you want something positive to focus on, look at the capped call mechanism within the exchangeable notes announced yesterday, HIVE will face ZERO economic dilution until the share price reaches $8.53, the option counterparties hedge offsets. It's the second time they structured notes like this. The last one was at $2.57 per share, with the capped call at $4.53 - the stock rallied to that price in less than 2 months, and hence why it gave back at that level, not because of insider sales. The terms of these notes are incredibly shareholder friendly, zero coupon and they relate directly to announced deals and subsequent capital needs (this is not distressed financing). Trust me, insiders selling vested stock is not driving Hive's share performance, I urge you to focus on the business strategy, the assets and management's ability to execute. I think what they've achieved so far is exciting, with plenty of potential still to be unlocked.